Carlos A B Ramirez
Overview
Explore the profile of Carlos A B Ramirez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramirez C, Mathews P, Madrid R, Garcia I, Rigoni V, Mertins O
Biomater Adv
. 2023 Jun;
153:213525.
PMID: 37352744
The upsurge of bacterial resistance to conventional antibiotics turned a well-recognized public health threat. The need of developing new biomaterials of effective practical use in order to tackle bacterial resistance...
2.
Ramirez C, Carriero M, Leomil F, Moro de Sousa R, Miranda A, Mertins O, et al.
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559240
The development of biomaterials to enable application of antimicrobial peptides represents a strategy of high and current interest. In this study, a bioparticle was produced by the complexation between an...
3.
Mathews P, Patta A, Madrid R, Ramirez C, Pimenta B, Mertins O
ACS Biomater Sci Eng
. 2021 Nov;
9(6):2911-2923.
PMID: 34779601
Nanodelivery of drugs aims to ensure drug stability in the face of adverse biochemical conditions in the course of administration, concomitant with appropriate pharmacological action provided by delivery at the...
4.
Madrid R, Mertins O, Tavares-Dias M, Flores-Gonzales A, Patta A, Ramirez C, et al.
J Fish Dis
. 2021 Aug;
44(11):1819-1829.
PMID: 34339060
Parasite infections in fish require constant surveillance and strategies for efficient treatments which guarantee the fish health, their sale value and the non-propagation of pathogens in new environments. Fish treatments...
5.
Madrid R, Mathews P, Patta A, Gonzales-Flores A, Ramirez C, Rigoni V, et al.
Heliyon
. 2021 Jan;
7(1):e05820.
PMID: 33426351
The FDA-approved drug ivermectin is applied for treatments of onchocerciasis and lymphatic filariasis. The anti-cancer and anti-viral activities have been demonstrated stressing possibilities for the drug repurposing and therefore new...